Objective: Sepsis poses a serious global health problem with an overall mortality rate of 30%, in which the vascular injury is a major contributor. The study is to determine the expression profile of micro-RNAs in endotoxic vascular walls and their potential roles in sepsis-related vascular injury. Design: Prospective randomized study. Setting: Laboratory investigation. Subjects: Male C57BL/6 mice, average weight 26.5 ± 1.8 g.
endothelial dysfunction and injury which lead to systemic vascular leakage and irreversible multiorgan failure. To date, the molecular mechanisms responsible for sepsis-induced injures on vascular integrity are still unclear.
Until recently, recombinant human-activated protein C, a coagulation protein, was the only Food and Drug Administration-approved adjunctive therapy for treating sepsis-related vascular injuries. However, in October 2011, it was withdrawn from the market after failure to demonstrate the improved patient survival in clinical applications (5) . This has highlighted the importance and urgency of studying the novel mechanisms and novel therapeutic targets of sepsis-induced vascular damages.
Micro-RNAs (mi-RNAs), with tremendous biological functions, are a class of endogenous, small, noncoding RNAs that directly regulate over 30% of genes in a cell (6) (7) (8) (9) . We are one of the first groups to explore the biological roles of mi-RNAs in vascular cell biology and vascular disease (10) . The studies from us (10) (11) (12) (13) (14) and other groups (15) have demonstrated that mi-RNAs play critical roles in vascular integrity, vascular inflammation, and vascular disease. mi-RNAs in sepsis are a novel research field in the past 5 years (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . In this regard, the levels of many mi-RNAs in circulating blood and several organ tissues are changed in animals and patients with sepsis (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . mi-RNAs could be novel diagnostic biomarkers and new therapeutic targets for sepsis (16) . However, to date, although the blood micro-RNAs are well studied in sepsis, the expression profiles of mi-RNAs in vascular walls in septic animals and septic patients, and their potential roles in sepsis-induced vascular injuries are still unknown.
To determine the potential roles of vascular mi-RNAs in sepsis-related vessel injuries and the potential mechanisms involved, we here use the mi-RNA microarray to determine the expression profile of mi-RNAs in the mouse aortas in a model of endotoxemia induced by lipopolysaccharide (LPS)injection and show that multiple mi-RNAs are aberrantly expressed in rat aortas after LPS injection. Among them, miR-126a-3p, an endothelial cell (EC)-enriched/EC-specific mi-RNA, is significantly down-regulated. miR-126 is a mi-RNA family, which includes miR-126a-3p, miR-126a-5p, miR-126b-3p, and miR-126b-5p. However, in normal vascular walls and vascular ECs, only miR-126a-3p is expressed. The aberrant expression of miR-126a-3p is also demonstrated in human septic vessels. We further demonstrated that miR-126a-3p plays an important role in endotoxemia-induced injuries on vascular integrity via its target genes.
MATERIALS AND METHODS

Animals
Male C57BL/6 mice (8-10 wk, 25-28 g) were used for this study. The animal protocol was approved by the Institutional Animal Care and Use Committee and was consistent with the Guide for the Care and Use of Laboratory Animals (NIH publication 85-23, revised 1985).
Endotoxemia Model and Endotoxin-Induced Death of Mice
Endotoxemia was induced in mice via LPS injection (20 mg/kg, intraperitoneal [IP]) (Sigma, St. Louis, MO) (26) (27) (28) . The control mice were injected with the same amount of saline (500 μL, IP). In a subgroup of mice, a high dose of LPS (30 mg/kg, IP) was applied to induce endotoxin-related death. The survival rate was monitored up to 7 days after LPS injection.
Mi-RNA Microarray in Mouse Aortas
In this experiment, the endotoxemia was induced in eight adult male C57BL/6 mice via LPS injection (20 mg/kg, IP). The control mice were injected with the same amount of saline (500 μL, IP). At 6 hours after LPS or vehicle injection, the aortas from mice were isolated for mi-RNA microarray analysis using the mouse mi-RNA array probes covering all the mi-RNAs in the latest version of the miRBase database as described previously (10) .
Human Skin Biopsy Samples and Skin Vessel Isolation
Under a microscope, human vessels were isolated from skin biopsy samples of septic patients (n = 5) and from non-septic control subjects (n = 5). All data were de-identified before being provided to the investigators. This study was approved by the research ethics committee, complied with the declaration of Helsinki, and the informed consent was provided by all subjects.
EC Isolation and Culture
ECs were isolated from mouse aortas (macro-vascular ECs) and mouse lung microvessels (microvascular ECs) under sterile conditions by established techniques (29, 30) . All the ECs were verified by the expression of endothelium-specific markers such as Ve-cadherin and CD31 and cultured with Cell Biologics' complete growth medium for ECs.
Modulation of MiR-126a-3p in Cultured ECs
To determine the potential cellular effects of miR-126a-3p on ECs, gain-of-function and loss-of-function approaches were applied. The expression of miR-126a-3p was down-regulated by its inhibitor, antago-miR-126a-3p (30 nM; Integrated DNA Technologies, Coralville, IA), and was upregulated via its mimics (miR-126a-3p mimics) (30 nM; Integrated DNA Technologies) as described in our previous studies (10) (11) (12) . Vehicle and oligonucleotide control (scrambled control) (Integrated DNA Technologies) were used as controls.
Cell Proliferation, Migration, and Apoptosis
EC proliferation was determined by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; thiazolyl blue assay and bromodeoxyuridine incorporation assay (11) . EC migration was determined by a modified Boyden chamber assay as described previously (11) . EC apoptosis in cultured cells was induced by treatment with H 2 O 2 (300 μM) for 24 hours. Apoptosis was measured by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analysis as described (11) . Apoptotic cells were quantified by counting the percentage of TUNEL-positive cells against total nucleated cells stained by 4′,6-diamidino-2-phenylindole dihydrochloride.
Generation of Recombinant Lentivirus Expressing miR-126a-3p and Adenovirus Expressing Krüppel-Like Factor 2
miR-126a-3p was constructed into the lentivirus expression vector using a lentivirus expressing system (Invitrogen, Carlsbad, CA) (LV-miR-126a-3p). Briefly, the oligonucleotides for miR-126a-3p were synthesized at Integrated DNA Technologies, annealed and ligated into pcDNATM6.2-GW/EmGFP-miR. The viral particles were produced by third-generation packaging in 293FT cells and were concentrated using ultracentrifugation. Adenovirus expressing Krüppel-like factor (KLF)-2 (Ad-KLF2) and its control virus (Ad-GFP) were generated using the Adeno-X Expression Systems 2 kit (Clontech Laboratories, Mountain View, CA) according to the manufacturer's protocols. The resulting adenoviruses were further amplified by infection of human embryonic kidney 293A cells (HEK 293A) and purified by cesium chloride gradient ultracentrifugation. The Ad-KLF2 and control Ad-GFP were titrated using a standard plaque assay.
Overexpression of MiR-126a-3p and KLF2 in Mice In Vivo
To overexpress miR-126a-3p in mouse aorta, 100 μL of LV-miR-126a-3p (2 × 10 8 plaque-forming units [PFU]) was injected into mice via external jugular vein. LV-Ctl (2 × 10 8 PFU) or vehicle (100 μL saline) was used as virus control and vehicle control. Seven days later, the overexpression of miR-126a-3p in mouse aortas was verified by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). To overexpress KLF2 in mouse aorta, 100 μL of Ad-KLF2 (2 × 10 8 PFU) was injected into mice via external jugular vein. Ad-GFP (2 × 10 8 PFU) was used as control.
Endothelial Function Assessment in Isolated Mouse Aortas
Isometric tension was measured in isolated mouse aortic ring segments as described (31) . The vessels were cut into individual ring segments (2-3 mm in width) and suspended from a force-displacement transducer in a tissue bath. Ring segments were bathed in Krebs-Henseleit (K-H) solution. The vessels were contracted to 50-60% of their maximal capacity (50-60% of KCl response) with phenylephrine (3 × 10 -8 -10 -7 M). When tension development reached a plateau, acetylcholine (10 -9 -3 × 10 -6 M) was added cumulatively to the bath to stimulate endothelium-dependent relaxation.
Vascular Permeability and Vascular Leakage
Vascular permeability and vascular leakage in vivo were determined based on the amounts of Evans blue extravasation into the peritoneal cavity (32, 33) and Evans blue leakage in lung (34) . For the Evans blue extravasation into the peritoneal cavity, at 6 hours after LPS injection (20 mg/kg, IP) or vehicle (saline) injection, Evans blue dye (20 mg/kg) in saline was injected IV into each mouse immediately followed by an intraperitoneal injection of 0.7% acetic acid. Thirty minutes later, the mice were killed and the peritoneal exudates were collected for Evans blue measurement. For the Evans blue leakage in lung, at 6 hours after LPS injection (20 mg/kg, IP) or vehicle (saline) injection, Evans blue dye solution (20 mg/ kg) in saline was injected IV into each mouse and was allowed to circulate for 1 hour. Then, mice were deeply anesthetized and perfused with saline plus 5 mM EDTA. Then, lungs were excised for Evans blue measurement.
RNA Isolation and qRT-PCR
RNAs levels were isolated and determined by qRT-PCR as described previously (11) . As an internal control, U6 was used for mi-RNA template normalization and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used for other genes.
Western Blot Analysis
Proteins isolated from ECs and vessels were determined by Western blot analysis. Equal amounts of protein were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis. A standard Western blot analysis was conducted using Sproutyrelated, EVH1 domain-containing protein 1 (SPRED1) rabbit polyclonal antibody (1:100 dilution; Abcam, Cambridge, MA), KLF2 rabbit polyclonal antibody (1:1,000 dilution; Abcam), and vascular cell adhesion molecule 1 (VCAM-1) rabbit polyclonal antibody (1:1,000 dilution; Abcam). GAPDH antibody (1:5,000 dilution; Cell Signalling, Danvers, MA) was used as a loading control.
Luciferase Assay
The reporter plasmid, a firefly luciferase reporter construct psiCHECK-2 (Promega, Fitchburg, WI) was inserted with a fragment of the 3′-untranslated region (UTR) of mouse SPRED1 mRNA or VCAM-1 mRNA containing the putative miR-126a-3p binding sequence. The construct with mutated fragment of the 3′-UTR of SPRED1 mRNA or VCAM-1 mRNA without the putative miR-126a-3p binding sequences was used as the mutated control. HEK 293 cells were transfected with the construct or the mutated control construct. Then, these HEK 293 cells were treated with vehicle, pDNR-CMV (an empty plasmid, 0.2 μg/mL), or pmiR-126a-3p (a plasmid expressing miR-126a-3p, 0.2 μg/mL). Cell extract was isolated to measure the luciferase expression on a scintillation counter by using a dual luciferase reporter system.
Statistical Analysis
All data are expressed as mean ± sem. All the experiments were repeated independently at least three times. For relative gene expression, the mean value of control group is defined as 100%. SPSS (IBM SPSS Statistics, Armonk, NY) was used to perform the statistical analysis. Analysis of variance (ANOVA) repeated measures was used to assess changes within a group, and oneway ANOVA within groups were used to assess the significance of any change between groups. Comparisons between two groups were performed using the independent samples t test. Statistical significance was accepted at p < 0.05.
RESULTS
Expression Profile of Mi-RNAs in Arteries From Endotoxic Mice Induced by LPS Injection
Compared with these in control vessels, we found that multiple mi-RNAs were aberrantly expressed in endotoxic mouse aortas. Table 1 listed these mi-RNAs that are abundant and aberrantly expressed in endotoxic mouse arteries. Interestingly, the EC-specific/enriched miR-126a-3p was significantly downregulated by about 50% in endotoxic aortas.
Verify the Down-Regulation of MiR-126a-3p in Endotoxic Mouse Arteries and in Vascular ECs Isolated From Endotoxic Aortas and Lungs by qRT-PCR
In this experiment, the expression of miR-126a-3p in mouse arteries and ECs isolated from mouse aortas and lungs was determined by qRT-PCR. Compared with that from control mice, the expression of miR-126a-3p in endotoxic mouse arteries was significantly down-regulated, which was consistent with the result determined by mi-RNA microarray analysis ( Fig.  1A) . Furthermore, the miR-126a-3p expression in ECs isolated from these endotoxic mouse aortas and lungs was also strongly down-regulated compared with that in cells from normal control mice (Fig. 1, B and C) .
The Expression Change of miR-126a-3p in Human Vessels From Patients With Sepsis
Mi-RNAs were isolated from these vessels, and miR-126a-3p levels were determined by qRT-PCR. We found that the expression of miR-126a-3p was significantly decreased in skin vessels from patients with sepsis ( Fig. 1D) .
MiR-126a-3p Has Strong Effects on the Proliferation, Migration, and Apoptosis of Cultured ECs
In this experiment, mouse ECs at passage 3-5 were used. The miR-126a-3p levels in these cells were modulated by miR-126a-3p mimics (30 nM) and antago-miR-126a-3p (30 nM) as demonstrated in Fig. 2A . Vehicle control and oligo control were applied in this experiment. As shown in Fig. 2 , B and D, cell proliferation and migration were increased by miR-126a-3p overexpression, but was inhibited by miR-126a-3p knockdown. In contrast, cell apoptosis was inhibited by miR-126a-3p overexpression, but was increased by miR-126a-3p knockdown (Fig. 2, E and F) .
Overexpression of MiR-126a-3p Attenuates LPS-Induced Cellular Effects on ECs
As shown in Fig. 3A , compared with vehicle-treated ECs, the expression of miR-126a-3p in LPS-treated ECs (100 ng/mL for 6 hr) was significantly decreased. At 24 hours after LPS-treatment, cell proliferation, migration, and apoptosis were determined. As shown Fig. 3, B-F , LPS damaged the functions of ECs as shown by the decreased proliferation and migration, and increased apoptosis. Interestingly, the impaired EC functions by LPS were partially inhibited by overexpression of miR-126a-3p via its mimics (30 nM) ( Fig. 3, B-F) . . 4A , compared with that in aortas from vehicle or LV-Ctl injected mice, the expression of miR-126a-3p in aortas from LV-miR-126a-3p injected was increased by about 2.5-fold. We found that LPS injection impaired endothelial function (endothelium-dependent relaxation) ( Fig. 4B) . Furthermore, LPS injection damaged the vascular barrier as shown by the increased Evans blue extravasation into the peritoneal cavity ( Fig. 4C) and Evans blue leakage in lung (Fig. 4D) .
Clearly, endotoxemia could significantly damage the vascular integrity via the impaired endothelial function and the increased vascular permeability. Interestingly, endotoxemiainduced injuries on vascular integrity were partially inhibited by miR-126a-3p overexpression ( Fig. 4, B-D) .
Overexpression of MiR-126a-3p via LV-MiR-126a-3p Reduces the Endotoxin-Induced Mortality in Mice
To test the role of miR-126a-3p in LPS-induced mortality, C57BL/6 mice were pretreated with vehicle, LV-Ctl or LV-miR-126a-3p. Seven days later, the animals were treated with high dose of LPS (30 mg/kg, IP). Each group had 20 mice. The survival of these mice was recorded up to 7 days after LPS-injection. As shown in Fig. 4E , miR-126a-3p overexpression significantly reduces the LPS-induced mortality in mice as shown by the increased survival rate. 
SPRED1 and VCAM-1 Are Two Direct Target Genes of miR-126a-3p That Are Involved in LPS-Induced Injures on ECs and Vascular Walls
Computational analysis via online software such as Tar-getScan 5.1 predicts that SPRED1 and VCAM-1 have miR-126a-3p binding sites in their 3′-UTR. Thus, there are potential direct target genes of miR-126a-3p. Bioinformatics analysis also suggests that these genes are related to cell proliferation, apoptosis, migration, senescence, and inflammation (oxidative stress). To identify that miR-126a-3p is able to directly bind to SPRED1 and VCAM-1 and inhibit their expression, a firefly luciferase reporter construct containing a fragment of the 3′-UTR of SPRED1 or VCAM-1 mRNA with the putative miR-126a-3p binding sequence or its truncated control was transfected into HEK 293 cells. As shown in Fig. 5A , pmiR-miR-126a-3p, but not pDNR-CMV, inhibited luciferase activity. The results suggest that miR-126a-3p could directly bind to and inhibit the expression of SPRED1 and VCAM-1. In cultured ECs, the expression of SPRED1 and VCAM-1 proteins were increased by miR-126a-3p inhibition. In contrast, their expression was down-regulated by miR-126a-3p overexpression (Fig. 5, B and C) . Furthermore, the expression of SPRED1 and VCAM-1 proteins was significantly increased in LPA-treated ECs in vitro (Fig. 5, D and  E) , in aortas from LPS-injected mice (Fig. 5, F and G) , and in vessels from patients with sepsis ( Fig. 5, H and I) in vivo.
KLF2 Is a Key Upstream Transcription Factor Involved in the Down-Regulation of MiR-126a-3p in Vascular ECs and Arteries in Endotoxemia
Mi-RNAs are subjected to transcriptional and posttranscriptional expressional regulation. To test which regulatory mechanism is responsible for the down-regulation of miR-126a-3p in endotoxemia, we first determined the levels of pri-miR-126a-3p in aortas from LPS-injected mice and in ECs treated with LPS by qRT-PCR. As shown in Fig. 6, A and B, the expression of pri-miR-126a-3p is remarkably decreased in endotoxic vessels and in ECs treated with LPS (100 ng/mL), which is consistent with the expression changes of mature miR-126a-3p in these cells and vessels. The results suggest that the down-regulation of mature miR-126a-3p in response to sepsis is mainly transcriptionally regulated. We next performed the experiments to uncover which transcription factor was involved in the transcriptional regulation of miR-126a-3p in sepsis. Putative regulatory elements flanking the pri-miR-126a-3p, by integrating publicly available encyclopedia of noncoding element datasets, were analyzed. By the results, we identified that the promoter of miR-126a-3p has binding sites for transcription factor KLF2. We then determined the levels of KLF2 in aortas from LPS-injected mice and in ECs treated with LPS. As shown in Fig. 6, C and D, its expression was remarkably decreased in endotoxic vessels and in ECs treated with LPS (100 ng/mL). To provide a direct link between KLF2 and miR-126a-3p expression, we created adenovirus expressing KLF2. As shown, Fig. 6, E and F, the expression of KLF2 in mouse aortas and in ECs was significantly increased by Ad-KLF2 in mice. Interestingly, LPS-induced down-regulation of miR-126a-3p in mouse aortas and ECs could be efficiently inhibited by KLF2 over-expression via Ad-KLF2 (Fig. 6, G and H) .
DISCUSSION
Mi-RNAs are able to directly regulate over 30% of genes in a cell. In addition, the remaining 70% might also be regulated indirectly by these noncoding RNAs. It is therefore not surprising that mi-RNAs are involved in the regulation of approximately all major cellular functions, such as cell proliferation, migration, and apoptosis. Accordingly, mi-RNAs could be critical regulators for physiology and diseases. More recently, the potential involvements of mi-RNAs in sepsis have been intensively studied both in endotoxic animal models and in patients with sepsis. In this regard, the expression In this experiment, the mouse ECs were pretreated with vehicle, control oligo (30 nM) or miR-126a-3p mimics (miR-126 mimics) (30 nM). Twenty-four hours later, the cells were treated with LPS (1 μg/mL) for 24 hr. Then, proliferation, migration, and apoptosis of these ECs were determined. One group of vehicle-treated cells without LPS-treatment was used as normal control cells. The levels of miR-126a-3p were determined by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). A, LPS decreased the expression of miR-126a-3p in ECs. n = 6; *p < 0.05 compared with that in control oligo-treated cells. B, Improved cell proliferation by miR-126a-3p overexpression determined by 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; thiazolyl blue assay. n = 6; *p < 0.05 compared with that in control oligo-treated cells. C, Improved cell proliferation by miR-126a-3p overexpression determined by bromodeoxyuridine assay. n = 6; *p < 0.05 compared with that in control oligo-treated cells. D, Improved cell migration by miR-126a-3p overexpression determined by Boyden chamber assay. n = 6; *p < 0.05 compared with that in control oligo-treated cells. E, Decreased cell apoptosis by miR-126a-3p overexpression determined by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. n = 6; *p < 0.05 compared with that in control oligo-treated cells. F, Representative cell images of TUNEL showing the apoptotic ECs with different treatments.
of multiple mi-RNAs in inflammatory cells is found to be strongly regulated by LPS both in vitro and in vivo (18, 35, 36) . Tili et al (35) identified, for the first time, that the expression of miR-155 and miR-125b in mouse Raw 264.7 macrophages was strongly regulated by LPS (34) . More excitingly, the levels of many plasma/serum mi-RNAs and whole blood mi-RNAs are remarkably changed in endotoxic animals and in patients with sepsis (22, 37, 38) . These blood mi-RNAs might be used as novel diagnostic biomarkers for sepsis (17, 23, 39) . In addition, the aberrant expression of mi-RNAs is also identified in some organs such as lung, liver, and heart from endotoxic animals (39) (40) (41) . These discoveries indicate that mi-RNAs might play important roles in sepsis. Indeed, modulation of one mi-RNA, micro-RNA-142-3p in dendritic cells could remarkably affect the endotoxin-induced mortality (18) .
Recent studies from us and other groups suggest that mi-RNAs in vascular cells play very important roles in vascular injuries, endothelial function, vascular integrity, and almost all types of vascular diseases (15) . For example, miR-145, miR-221/222, miR-21, and miR-31 are critical regulators for vascular smooth muscle cell function and vascular neointimal formation, whereas miR-126a-3p, miR-124, miR-34a, and miR-146a have strong effects on EC function and endothelial function (9) . However, to date, the expression profiles of mi-RNAs in vascular walls in endotoxic animals and septic patients and their potential roles in sepsis-related vascular barrier injuries are still unknown. ) or LV-miR-126a-3p (LV-miR-126a) (2 × 10 8 PFU) via external jugular vein. Seven days later, miR-126a-3p expression in aortas was determined. Then, the animals will be treated with vehicle (500 μL of saline, intraperitoneal [IP]) or LPS (20 mg/kg, IP). Six hours later, the vascular permeability in vivo and endothelial function in isolated aortas were determined. A, MiR-126a-3p expression in mouse aortas was increased by LV-miR-126a-3p. n = 6; *p < 0.05 compared with that in aortas from LV-Ctl-treated mice. B, miR-126a-3p overexpression inhibited LPS-induced endothelial dysfunction in endotoxic mice. n = 8; *p < 0.05 compared with that in LV-Ctl-treated mice. C, MiR-126a-3p overexpression inhibited LPS-induced abnormal Evans blue extravasation into the peritoneal cavity in mice. n = 8; *p < 0.05 compared with that in LV-Ctl-treated mice. D, MiR-126a-3p overexpression inhibited LPS-induced abnormal Evans blue leakage in lung in mice. Note: n = 6; *p < 0.05 compared with that in LV-Ctl-treated mice. E, For LPS-induced mortality, C57BL/6 mice were pretreated with vehicle, LV-Ctl or LV-miR-126a-3p. Seven days later, the animals were treated with high dose of LPS (30 mg/kg, IP) to induce animal death. The survival rate of these mice was recorded up to 7 d after LPS-injection. n = 20; *p < 0.05 compared with that in LV-Ctl-treated mice.
In this study, we thus determined the expression profile of mi-RNAs in aortas from LPS-induced endotoxic mice. Clearly, multiple vascular mi-RNAs were aberrantly expressed in endotoxic mouse arteries. Among them, miR-126a-3p is significantly down-regulated by about 50% in septic mouse aortas and in septic human vessels. miR-126a-3p is an EC-enriched and EC-specific mi-RNA. Recent studies have revealed that miR-126a-3p plays important roles in proliferation, migration, and apoptosis of vascular ECs, in angiogenesis as well as in vascular diseases such as atherosclerosis (42) (43) (44) (45) (46) . We are focused on miR-126a-3p in this study to test its potential involvement in endotoxemia-induced vascular damages. However, other mi-RNAs in Table 1 such as miR-378, miR-16, and miR-26, which were aberrantly expressed in endotoxic vessels, are also significant enough for investigation in future studies.
We hypothesized that miR-126a-3p might be a critical participant in sepsis-related injuries on vascular ECs and vascular integrity. To test it, we first determined the levels of miR-126a-3p in aortic ECs from endotoxic mice. The result demonstrated that the expression of miR-126a-3p was significantly down-regulated in ECs from septic mice. In addition, miR-126a-3p was also down-regulated in ECs after treatment with LPS. By both gainof-function and loss-of-function approaches, we found that miR-126a-3p had strong effects on apoptosis, proliferation, and migration of ECs. The results are consistent with recent studies from other groups (42) (43) (44) (45) (46) . Thus, down-regulation of miR-126a-3p could be a novel mechanism in sepsis-mediated injuries on vascular ECs. To further test our hypothesis, miR-126a-3p mimics was applied in cultured ECs before they were damaged by LPS. We found that LPS-induced injuries on ECs were attenuated via miR-126a-3p overexpression, as shown by the improved proliferation, migration, and the reduced apoptosis.
Sepsis induced by LPS injection elicits endothelial dysfunction and the increased vascular permeability. To test the potential roles of miR-126a-3p in sepsis-induced injuries on vascular integrity, we generated lentivirus expressing miR-126a-3p and applied it to mice. We found that LPS-induced endothelial dysfunction and vascular leakage were partially inhibited by miR-126a-3p treatment. Vascular damages such as endothelial dysfunction and vascular leakage in sepsis are critical contributors in sepsis-induced mortality. As we found that miR-126a-3p had strong effects on LPS-induced vascular damages, we finally determined the effect of miR-126a-3p on mortality of endotoxemia. Our result demonstrated that the survival rate of endotoxic mice was significantly improved by the overexpression of miR-126a-3p.
SPRED1 and VCAM-1 are two genes that are related to cell proliferation, apoptosis, migration, senescence, and inflammation. In addition, both SPRED1 and VCAM-1 are key molecules in EC activation and vascular permeability (47) (48) (49) . Recent studies have identified that they are direct target genes of miR-126a-3p (43, 44) . Our luciferase assay and both gainof-function and loss-of-function approaches verified that these two genes are indeed the direct target genes in vascular ECs. To further confirm that SPRED1 and VCAM-1 may be involved in sepsis, we determined the protein levels of SPRED1 and VCAM-1 and found that they are indeed increased in LPS-treated ECs and in vessels from LPS-injected mice and from patients with sepsis. Furthermore, we found that the increased expression of SPRED1 and VCAM-1 was significantly inhibited by overexpression of miR-126a-3p both in vitro and in vitro.
It is well established that mi-RNAs are subjected to transcriptional and posttranscriptional expressional regulation. One recent study has reported that KLF2 is a strong regulator for the expression of mi-RNAs in ECs (50) . In this study, we identified that the down-regulation of miR-126a-3p in sepsis was mainly induced by transcriptional inhibition due to the deceased expression of its binding transcription factor KLF2. Indeed, the expression of KLF2 was decreased in ECs and vascular walls in endotoxemia. In addition, LPS-induced down-regulation both in ECs and mouse vessels could be efficiently inhibited by KLF2 over-expression via Ad-KLF2.
There are some limitations in this study. First, the murine model was used in this project, which might be different in humans. Thus, more human studies should be performed. Second, the LPS-injected mice are model of endotoxemia. Although the vascular damages share many aspects with bacterial sepsis-induced vascular injuries, they are still different. Third, this study is the first to explore the role of miR-126a-3p in an animal model of vascular dysfunction due to systemic inflammation. However, the roles of miR-126a-3p in endothelial proliferation and apoptosis are well documented. Fourth, the cellular functions of miR-126a-3p are mainly determined in cultured ECs in vitro. These findings should be translated into the in vivo vascular response and sepsis both in animal and in human in future studies. Fifth, the LV-miR-126 we used in this study is not specific for ECs. Thus, it is possible that the secondary effect of other tissues infected with LV-miR-126 may also lead to endothelial injuries.
In summary, as shown in Fig. 7 , in this study, we have identified that microbial virulence factors and numerous proinflammatory mediators in blood under septic condition are able to down-regulate the expression of miR-126a-3p in vascular ECs and in vascular walls. The down-regulated miR-126a-3p could result in the increase of its target genes such as SPRED1, VCAM-1, etc, and induce vascular injuries such as increased EC apoptosis, decreased EC proliferation, increased EC permeability, impaired vascular functions including endothelial dysfunction, and increased vascular leakage. The breakdown of vascular integrity could induce irreversible multiorgan failure and sepsis-related death. Thus, miR-126a-3p may represent a novel mechanism and a new therapeutic target for sepsis and its related vascular complications. Figure 7 . Schematic representation shows a miR-126a-3p mechanism of sepsis-related injuries on vascular endothelial cells (ECs) and vascular integrity. Endotoxemia in sepsis is able to down-regulate the expression of EC-enriched miR-126a-3p in the vascular walls via Krüppel-like factor (KLF)-2. The down-regulation of miR-126a-3p could induce endothelial dysfunction, and vascular leakage via their target genes such as SPRED1 (Sprouty-related, EVH1 domain-containing protein 1) and VCAM-1 (vascular cell adhesion molecule 1) that could induce vascular injury, irreversible multiorgan failure and sepsis-related death.
